Exelixis (EXEL) Tops Q3 EPS by 9c, provides guidance

Exelixis (NASDAQ: EXEL) reported Q3 EPS of $0.78, $0.09 better than the analyst estimate of $0.69. Revenue for the quarter came in at $597.8 million versus the consensus estimate of $590.47 million.

GUIDANCE:

Exelixis sees FY2025 revenue of $2.3-2.35 billion, versus the consensus of $2.319 billion.

For earnings history and earnings-related data on Exelixis (EXEL) click here.

You May Also Be Interested In

• BofA maintains underperform ratings on six BDC stocks
• OBOOK Holdings posts $18.8M net loss as OwlPay Harbor volume rises
• Cytek faces $56M damages award in Beckman Coulter patent case